Search concepts
|
Selected Filters
|
- 1 - 25 out of 32,454 results
Search results
-
Active
Cosmological Simulation Analysis for the LSST Dark Energy Science Collaboration
Starkenburg, T. (PD/PI)
UChicago Argonne, LLC, Argonne National Laboratory, Department of Energy
6/2/25 → 8/29/25
Project: Research project
-
Advanced Rehabilitation Research Training (ARRT) Program - Community Living and Participation
Bilaver, L. A. (PD/PI) & Jordan, N. (Co-PD/PI)
National Institute on Disability, Independent Living, and Rehabilitation Research
6/1/25 → 5/31/26
Project: Research project
-
Targeting translational remodeling in Squamous Cell Carcinoma (SCC)
Sangwan, S. (PD/PI)
6/1/25 → 5/31/26
Project: Research project
-
eBERlight, a virtual Collaborative Access Team at the Advanced Photon Source
Jacobsen, C. (PD/PI)
UChicago Argonne, LLC, Argonne National Laboratory, Department of Energy
6/1/25 → 11/30/25
Project: Research project
-
Advanced Rehabilitation Research Training: Interventions for Neurologic Communication Disorders
Cherney, L. R. (PD/PI)
National Institute on Disability, Independent Living, and Rehabilitation Research
6/1/25 → 5/31/26
Project: Research project
-
Prevention of cardiovascular disease and mortality in patients with psoriasis or psoriatic arthritis: Translating guidelines of care to better outcomes for patients with psoriatic disease
Vakharia, P. P. (PD/PI)
University of Pennsylvania, National Psoriasis Foundation
5/29/25 → 5/29/28
Project: Research project
-
Prot #BH-30236-01: A Phase 1/1b Open-Label, Dose Escalation, First-in-Human Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Preliminary Anti-leukemic Activity of the Orally Available CDC-Like Kinase (CLK) Inhibitor, BH-30236, in Adults
Altman, J. K. (PD/PI)
Pharmaceutical Research Associates, Inc., BlossomHill Therapeutics, Inc.
5/28/25 → 5/28/28
Project: Research project
-
Prot #NKT2152-101: A Phase 1/2, Open Label Dose-Escalation and Expansion Trial of NKT2152, an Orally Administered HIF-2α Inhibitor, to Investigate Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity in Patients with Advanced Clear Cell Renal
VanderWeele, D. J. (PD/PI)
Medpace Clinical Research LLC, NiKang Therapeutics, Inc.
5/23/25 → 5/23/28
Project: Research project
-
Prot #ASI-CL-0301: A phasE 3, open-label, multiceNter, randomized crossover trial comparing tHe safety and efficAcy of ASI-02 to agitated saline for suspected right-to-left shunt (ENHANCE Study)
Narang, A. (PD/PI)
Bright Research Partners, Inc., Agitated Solutions Inc.
5/23/25 → 5/23/28
Project: Research project
-
Prot #HPN-CTCL-03-EUR: A Confirmatory Phase 3 Multicenter, Randomized, Double-Blind, Placebo Controlled Study of the Efficacy of Topical HyBryte™ (Hypericin Sodium) and Visible-Light Activation for the Treatment of Cutaneous T-Cell Lymphoma (CTCL)
Zhou, A. (PD/PI)
5/15/25 → 5/15/28
Project: Research project
-
Prot #TP0081: SEAL™ IT: Saccular Endovascular Aneurysm Lattice System Interventional Pivotal Trial
Abdalla, R. (PD/PI)
5/15/25 → 5/15/28
Project: Research project
-
Prot #CLIN-0036: Pivotal Study to Evaluate the Safety and Effectiveness of the CereVasc® eShunt® System in the Treatment of Normal Pressure Hydrocephalus (STRIDE)
Potts, M. B. (PD/PI)
5/14/25 → 5/14/28
Project: Research project
-
Prot #AMT-162-001: EPISOD1: A Phase 1/2, Multicenter, Single Ascending Dose Study to Evaluate the Safety, Tolerability, and Exploratory Efficacy of Intrathecally Administered Gene Therapy AMT-162 in Adult Participants with SOD1 Amyotrophic Lateral Scleros
Ajroud-Driss, S. (PD/PI)
Pharmaceutical Research Associates, Inc., uniQure Biopharma B.V.
5/9/25 → 5/9/28
Project: Research project
-
Prot #Pz-cel-RY-401: A Long-Term Safety Follow-up Registry for Patients Who Received Treatment with Prademagene Zamikeracel for Recessive Dystrophic Epidermolysis Bullosa (RDEB) in the Post-Marketing Setting
Paller, A. (PD/PI)
WE Pharma, Inc, Abeona Therapeutics Inc.
5/9/25 → 5/9/28
Project: Research project
-
Prot #1462-0004: A Randomised, Double-Blind, Placebo-Controlled, Dose-Finding Study Evaluating Efficacy, Safety, and Tolerability of Different Oral Doses of BI 1819479 Over at Least 24 Weeks in Patients with Idiopathic Pulmonary Fibrosis (IPF)
Warrior, K. (PD/PI)
Boehringer Ingelheim Pharmaceuticals, Inc.
5/7/25 → 5/7/26
Project: Research project
-
Prot #77242113PSO3006: A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled and Ustekinumab Active Comparator-Controlled Study to Evaluate the Efficacy and Safety of JNJ-77242113 for the Treatment of Participants With Moderate to Severe Pla
Vakharia, P. P. (PD/PI)
Janssen Research & Development, LLC
5/6/25 → 12/8/28
Project: Research project
-
BIA: A Co-Design Methodology to Transform Materials and Computer Architecture
Hersam, M. (PD/PI)
UChicago Argonne, LLC, Argonne National Laboratory, Department of Energy
5/6/25 → 5/5/29
Project: Research project
-
Compound Evaluation in Scn1a+/- Dravet Mice
Kearney, J. A. (PD/PI) & Hawkins, N. A. (Other)
5/5/25 → 5/4/26
Project: Research project
-
Prot #M23-699: SELECT-SLE: A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Moderately to Severely Active SLE
Blanco, I. (PD/PI)
5/5/25 → 5/5/28
Project: Research project
-
Developing a Dual Targeting siRNASO Oligonucleotide Therapy for Amyotrophic Lateral Sclerosis Patients
Kiskinis, E. (PD/PI)
5/1/25 → 4/30/27
Project: Research project
-
Differential Vulnerability of White Matter in CBD versus PSP leading to Primary Progressive Aphasia
Gefen, T. D. (PD/PI)
5/1/25 → 8/30/25
Project: Research project
-
Multimodal classification and sub-cellular compartmentalization of displaced amacrine cells in the mouse retina
Schwartz, G. W. (PD/PI)
5/1/25 → 3/31/30
Project: Research project
-
World Congress on Justice with Children
McGrath, S. A. (PD/PI)
Harry Frank Guggenheim Foundation
5/1/25 → 6/30/25
Project: Research project
-
AI4POC - Harnessing AI for Extracting Insights from Postoperative Complications
Barber, E. L. (PD/PI)
5/1/25 → 10/31/25
Project: Research project